Nukkleus Flags Non-Compliance with SEC Filing Requirements
Ticker: DFNSW · Form: 10-Q/A · Filed: Jul 9, 2025 · CIK: 1787518
Sentiment: bearish
Topics: SEC Filings, Regulatory Compliance, 10-Q/A, Non-Compliance, Nasdaq Delisting Risk, Smaller Reporting Company, Emerging Growth Company
Related Tickers: DFNSW, NUKK, NUKKW
TL;DR
**Nukkleus's failure to file required SEC reports is a massive red flag, signaling deep operational issues and making it uninvestable until compliance is restored.**
AI Summary
Nukkleus Inc. filed an Amendment No. 1 to its Form 10-Q for the quarterly period ended March 31, 2025. The filing indicates that Nukkleus Inc. is a non-accelerated filer, a smaller reporting company, and an emerging growth company. A significant disclosure is that the registrant has *not* filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, nor has it been subject to such filing requirements for the past 90 days, as indicated by the 'No' checkmark. However, the company *has* submitted electronically every Interactive Data File required pursuant to Rule 405 of Regulation S-T during the preceding 12 months. The company's common stock (NUKK) and warrants (NUKKW) are registered on The Nasdaq Stock Market LLC. The amendment itself does not provide updated financial figures for revenue or net income, focusing instead on regulatory compliance status and company classification.
Why It Matters
This filing is critical for investors as it reveals Nukkleus Inc. has not met its SEC reporting obligations for the past year, signaling potential governance and operational issues. This non-compliance can erode investor confidence, lead to delisting risks from Nasdaq, and significantly impact the company's ability to raise capital. Competitors in the management consulting services sector, like Accenture or Deloitte, maintain rigorous compliance, making Nukkleus's lapse a stark contrast that could deter new business and talent. Employees might face uncertainty regarding the company's stability, while customers could question its reliability and long-term viability.
Risk Assessment
Risk Level: high — The risk level is high because Nukkleus Inc. explicitly indicated 'No' to having filed all required reports under Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months. This non-compliance with fundamental regulatory obligations poses a severe threat of delisting from Nasdaq and significantly impairs investor trust.
Analyst Insight
Investors should immediately divest from Nukkleus Inc. (DFNSW) given its stated non-compliance with SEC filing requirements. This regulatory lapse indicates significant underlying operational or governance problems that make the stock highly speculative and risky.
Key Numbers
- 12 months — period of non-compliance (Nukkleus Inc. has not filed all required reports during this period.)
- 90 days — period of non-compliance (Nukkleus Inc. has not been subject to filing requirements for this period.)
- 20250331 — Conformed Period of Report (The quarter for which the 10-Q/A was filed.)
- 20250709 — Filed As Of Date (The date the 10-Q/A was filed.)
- 001-39341 — Commission File Number (Unique identifier for Nukkleus Inc.'s SEC filings.)
Key Players & Entities
- Nukkleus Inc. (company) — registrant of the 10-Q/A filing
- The Nasdaq Stock Market LLC (regulator) — exchange where NUKK and NUKKW are registered
- SEC (regulator) — regulator for Section 13 or 15(d) filings
- Brilliant Acquisition Corp (company) — former name of Nukkleus Inc.
- March 31, 2025 (date) — end of the quarterly period reported
- July 9, 2025 (date) — filing date of the 10-Q/A
- 001-39341 (regulator) — Commission file number
- 575 Fifth Avenue, 14th Floor, New York, New York 10017 (company) — principal executive offices of Nukkleus Inc.
- $0.0001 (dollar_amount) — par value per share of common stock
- $92.00 (dollar_amount) — exercise price per share for warrants
FAQ
What is the primary issue disclosed in Nukkleus Inc.'s 10-Q/A filing?
The primary issue is that Nukkleus Inc. has not filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, nor has it been subject to such filing requirements for the past 90 days.
What are the potential consequences for Nukkleus Inc. due to its SEC filing non-compliance?
Potential consequences for Nukkleus Inc. include a significant loss of investor confidence, increased risk of delisting from The Nasdaq Stock Market LLC, and challenges in raising future capital, all stemming from its failure to meet regulatory obligations.
Is Nukkleus Inc. considered a large accelerated filer?
No, Nukkleus Inc. is not a large accelerated filer. The 10-Q/A filing explicitly states that the company is a non-accelerated filer, a smaller reporting company, and an emerging growth company.
What is the trading symbol for Nukkleus Inc. common stock?
The trading symbol for Nukkleus Inc. common stock is NUKK, and it is registered on The Nasdaq Stock Market LLC.
Has Nukkleus Inc. submitted all required Interactive Data Files?
Yes, Nukkleus Inc. has submitted electronically every Interactive Data File required pursuant to Rule 405 of Regulation S-T during the preceding 12 months, despite other filing deficiencies.
What is the par value of Nukkleus Inc.'s common stock?
The par value of Nukkleus Inc.'s common stock is $0.0001 per share, as stated in the 10-Q/A filing.
When was the quarterly period for which Nukkleus Inc.'s 10-Q/A was filed?
The 10-Q/A for Nukkleus Inc. was filed for the quarterly period ended March 31, 2025, with the filing date being July 9, 2025.
What was Nukkleus Inc.'s former company name?
Nukkleus Inc.'s former company name was Brilliant Acquisition Corp, with the name change occurring on September 9, 2019.
Where are Nukkleus Inc.'s principal executive offices located?
Nukkleus Inc.'s principal executive offices are located at 575 Fifth Ave, 14th Floor, New York, New York 10017.
What is the exercise price for Nukkleus Inc. warrants?
Each warrant for Nukkleus Inc. is exercisable for one share of Common Stock for $92.00 per share, and these warrants trade under the symbol NUKKW.
Risk Factors
- Failure to File Required Reports [high — regulatory]: Nukkleus Inc. has indicated it has not filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months. Furthermore, the company has not been subject to such filing requirements for the past 90 days. This non-compliance poses a significant regulatory risk.
- Interactive Data File Compliance [medium — regulatory]: While the company has submitted all required Interactive Data Files electronically for the preceding 12 months, the overall reporting deficiency could lead to scrutiny from regulatory bodies.
Industry Context
Nukkleus Inc. operates within the management consulting services sector (SIC 8742). This industry is characterized by a wide range of firms, from large global consultancies to specialized boutique firms. Key trends include digital transformation, data analytics, and sustainability consulting. Competition is often based on expertise, client relationships, and the ability to deliver measurable results.
Regulatory Implications
The company's admission of not filing all required reports under Section 13 or 15(d) of the Exchange Act for the past 12 months is a significant regulatory concern. This non-compliance could lead to SEC enforcement actions, fines, or delisting from the Nasdaq Stock Market if not rectified promptly.
What Investors Should Do
- Review the full amended filing for details on the reasons for non-compliance.
- Monitor future filings for evidence of compliance restoration.
- Assess the impact of potential regulatory actions on the company's operations and stock price.
Key Dates
- 2025-03-31: Quarterly Period End — This is the end date of the fiscal quarter for which the amended 10-Q filing pertains.
- 2025-07-09: Filing Date of 10-Q/A — This is the date Amendment No. 1 to the Form 10-Q was filed with the SEC, indicating the company is providing updated information or corrections.
Glossary
- 10-Q/A
- An amended quarterly report filed with the U.S. Securities and Exchange Commission (SEC) to correct or supplement information previously filed in a Form 10-Q. (This filing indicates Nukkleus Inc. is providing updated or corrected information for its quarterly financial reporting.)
- Non-accelerated filer
- A category of public company defined by the SEC that does not meet the thresholds for accelerated or large accelerated filer status, generally indicating a smaller market capitalization. (Nukkleus Inc. is classified as a non-accelerated filer, suggesting it is a smaller company in terms of market size.)
- Smaller reporting company
- A company that meets certain SEC criteria for revenue and public float, allowing for scaled disclosure requirements. (Nukkleus Inc. is also a smaller reporting company, which may impact the extent of financial information it is required to disclose.)
- Emerging growth company
- A company that has total annual gross revenues of less than $1.235 billion during its most recently completed fiscal year and meets other criteria, allowing for certain regulatory accommodations. (Nukkleus Inc. is an emerging growth company, which may benefit from extended transition periods for adopting new accounting standards.)
- Section 13 or 15(d) of the Securities Exchange Act of 1934
- These sections of the Exchange Act mandate periodic reporting requirements for companies whose securities are registered with the SEC. (The filing explicitly states Nukkleus Inc. has not met these reporting requirements for the preceding 12 months, highlighting a compliance issue.)
- Interactive Data File
- Electronic files submitted to the SEC in a machine-readable format (e.g., XBRL) that allows for automated analysis of financial information. (Nukkleus Inc. has complied with submitting these files, indicating a partial adherence to modern electronic filing standards.)
Year-Over-Year Comparison
This filing is an amendment (10-Q/A) to a previous quarterly report for the period ended March 31, 2025. As it is an amendment, it primarily addresses compliance status rather than providing new financial performance figures compared to the original filing. The key change highlighted is the company's admission of not having filed all required reports in the preceding 12 months, which is a critical disclosure not present in the initial filing.
Filing Details
This Form 10-Q/A (Form 10-Q/A) was filed with the SEC on July 9, 2025 regarding Nukkleus Inc. (DFNSW).